Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | Apr. 28, 2023 | |
Cover [Abstract] | ||
Entity Registrant Name | XPERI INC. | |
Trading Symbol | XPER | |
Entity Central Index Key | 0001788999 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 42,517,613 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | Yes | |
Entity Shell Company | false | |
Entity File Number | 001-41486 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 83-4470363 | |
Entity Address, Address Line One | 2190 Gold Street | |
Entity Address, City or Town | San Jose | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 95002 | |
City Area Code | 408 | |
Local Phone Number | 519-9100 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Security12b Title | Common Stock (par value $0.001 per share) | |
Security Exchange Name | NYSE |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue: | $ 126,839 | $ 118,888 |
Operating expenses: | ||
Cost of revenue, excluding depreciation and amortization of intangible assets | 27,792 | 27,407 |
Research and development | 54,856 | 50,200 |
Selling, general and administrative | 57,776 | 49,852 |
Depreciation expense | 4,093 | 5,563 |
Amortization expense | 14,827 | 14,792 |
Impairment of long-lived assets | 1,096 | |
Total operating expenses | 160,440 | 147,814 |
Operating loss | (33,601) | (28,926) |
Other income , net | 368 | 515 |
Loss before taxes | (33,233) | (28,411) |
(Benefit from) provision for income taxes | (294) | 2,080 |
Net loss | (32,939) | (30,491) |
Less: net loss attributable to noncontrolling interest | (939) | (968) |
Net loss attributable to the Company | $ (32,000) | $ (29,523) |
Loss per share attributable to the Company: | ||
Basic loss per share | $ (0.76) | $ (0.70) |
Diluted loss per share | $ (0.76) | $ (0.70) |
Weighted-average number of shares used in per share calculations - basic | 42,224 | 42,024 |
Weighted-average number of shares used in per share calculations - diluted | 42,224 | 42,024 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net loss | $ (32,939) | $ (30,491) |
Other comprehensive income (loss): | ||
Change in foreign currency translation adjustment | 613 | (1,046) |
Unrealized gain on cash flow hedges | 863 | |
Comprehensive loss | (31,463) | (31,537) |
Less: comprehensive loss attributable to noncontrolling interest | (939) | (968) |
Comprehensive loss attributable to the Company | $ (30,524) | $ (30,569) |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | |
Current assets: | |||
Cash and cash equivalents | $ 110,696 | $ 160,127 | |
Accounts receivable, net | 70,704 | 64,712 | |
Unbilled contracts receivable, net | 69,120 | 65,251 | |
Other current assets | 46,836 | 42,174 | |
Total current assets | 297,356 | 332,264 | |
Long-term unbilled contracts receivable | 9,563 | 4,289 | |
Property and equipment, net | 47,082 | 47,827 | |
Operating lease right-of-use assets | 47,041 | 52,901 | |
Intangible assets, net | 249,681 | 264,376 | |
Long-term deferred tax assets | 2,283 | 2,096 | |
Other long-term assets | 34,205 | 33,158 | |
Total assets | 687,211 | 736,911 | |
Current liabilities: | |||
Accounts payable | 13,756 | 14,864 | |
Accrued liabilities | 87,358 | 110,014 | |
Deferred revenue | 24,593 | 25,363 | |
Total current liabilities | 125,707 | 150,241 | |
Long-term deferred tax liabilities | 12,886 | 12,899 | |
Deferred revenue, noncurrent | 18,766 | 19,129 | |
Long-term debt, net | 50,000 | 50,000 | |
Operating lease liabilities, noncurrent | 37,450 | [1] | 42,666 |
Other long-term liabilities | 11,828 | 12,990 | |
Total liabilities | 256,637 | 287,925 | |
Commitments and contingencies (Note 15) | |||
Equity: | |||
Preferred stock: $0.001 par value; 6,000 shares authorized as of March 31, 2023 and December 31, 2022; no shares issued and outstanding as of March 31, 2023 and December 31, 2022 | |||
Common stock: $0.001 par value; 140,000 shares authorized as of March 31, 2023 and December 31, 2022; 42,497 and 42,066 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively | 42 | 42 | |
Additional paid-in capital | 1,149,370 | 1,136,330 | |
Accumulated other comprehensive loss | (2,643) | (4,119) | |
Accumulated deficit | (700,835) | (668,835) | |
Total Company stockholders' equity | 445,934 | 463,418 | |
Noncontrolling interest | (15,360) | (14,432) | |
Total equity | 430,574 | 448,986 | |
Total liabilities and equity | $ 687,211 | $ 736,911 | |
[1] Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes. |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 6,000,000 | 6,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 140,000,000 | 140,000,000 |
Common stock, shares issued (in shares) | 42,497,000 | 42,066,000 |
Common stock, shares outstanding (in shares) | 42,497,000 | 42,066,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (32,939) | $ (30,491) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation of property and equipment | 4,093 | 5,563 |
Amortization of intangible assets | 14,827 | 14,792 |
Stock-based compensation expense | 15,968 | 8,637 |
Deferred income taxes | (200) | 190 |
Impairment of long-lived assets | 1,096 | |
Other | 1,000 | (414) |
Changes in operating assets and liabilities: | ||
Accounts receivable | (6,019) | 20,785 |
Unbilled contracts receivable | (9,124) | (3,116) |
Other assets | (5,709) | (3,991) |
Accounts payable | (1,108) | 1,240 |
Accrued and other liabilities | (23,855) | (26,562) |
Deferred revenue | (1,133) | (4,997) |
Net cash used in operating activities | (43,103) | (18,364) |
Cash flows from investing activities: | ||
Purchases of property and equipment | (3,861) | (4,345) |
Purchases of intangible assets | (68) | (20) |
Net cash used in investing activities | (3,929) | (4,365) |
Cash flows from financing activities: | ||
Withholding taxes related to net share settlement of restricted awards | (2,917) | |
Net transfers from Former Parent | 25,754 | |
Net cash (used in) provided by financing activities | (2,917) | 25,754 |
Effect of exchange rate changes on cash and cash equivalents | 518 | (385) |
Net (decrease) increase in cash and cash equivalents | (49,431) | 2,640 |
Cash and cash equivalents at beginning of period | 160,127 | 120,695 |
Cash and cash equivalents at end of period | 110,696 | 123,335 |
Supplemental disclosure of cash flow information: | ||
Interest paid | 1,496 | |
Income taxes paid, net of refunds | $ 1,603 | $ 3,234 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Net Investment by Former Parent | Accumulated Other Comprehensive Loss | Accumulated Deficit | Noncontrolling Interest |
Beginning balance at Dec. 31, 2021 | $ 1,015,957 | $ 1,025,838 | $ (676) | $ (9,205) | |||
Issuance of equity to noncontrolling interest | 4 | 4 | |||||
Other comprehensive income (loss) | (1,046) | (1,046) | |||||
Net loss | (30,491) | (29,523) | (968) | ||||
Net transfers from Former Parent | 34,389 | 34,389 | |||||
Ending balance at Mar. 31, 2022 | 1,018,813 | $ 1,030,704 | (1,722) | (10,169) | |||
Beginning balance at Dec. 31, 2022 | 448,986 | $ 42 | $ 1,136,330 | (4,119) | $ (668,835) | (14,432) | |
Beginning balance (in shares) at Dec. 31, 2022 | 42,066,000 | ||||||
Issuance of equity to noncontrolling interest | (11) | 11 | |||||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes | (2,917) | (2,917) | |||||
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes, (in shares) | 431,000 | ||||||
Stock-based compensation | 15,968 | 15,968 | |||||
Other comprehensive income (loss) | 1,476 | 1,476 | |||||
Net loss | (32,939) | (32,000) | (939) | ||||
Ending balance at Mar. 31, 2023 | $ 430,574 | $ 42 | $ 1,149,370 | $ (2,643) | $ (700,835) | $ (15,360) | |
Ending balance (in shares) at Mar. 31, 2023 | 42,497,000 |
The Company and Basis of Presen
The Company and Basis of Presentation | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
The Company and Basis of Presentation | NOTE 1 – THE COMPANY AND BASIS OF PRESENTATION Xperi Spin-Off In June 2020, Xperi Holding Corporation (“Xperi Holding,” “Adeia,” or the “Former Parent”) announced plans to separate into two independent publicly-traded companies (the “Separation”), one comprising its intellectual property (“IP”) licensing business and one comprising its product business (“Xperi Product”). On October 1, 2022, the Former Parent completed the Separation (the “Spin-Off”) through a pro-rata distribution (the “Distribution”) of all the outstanding common stock of its product-related business (formerly known as Xperi Product, and hereinafter “Xperi Inc.”, “Xperi” or the “Company”) to the stockholders of record of the Former Parent as of the close of business on September 21, 2022 , the record date (the “Record Date”) for the Distribution. Each Xperi Holding stockholder of record received four shares of Xperi common stock, $ 0.001 par value, for every ten shares of Xperi Holding common stock, $ 0.001 par value, held by such stockholder as of the close of business on the Record Date. As a result of the Distribution, Xperi became an independent, publicly-traded company and its common stock is listed under the symbol “XPER” on the New York Stock Exchange (“NYSE”). In connection with the Separation and the Distribution, Xperi Holding was renamed and continues as Adeia Inc. and also changed its stock symbol to “ADEA” on the Nasdaq Global Select Market. Description of Business Xperi is a leading consumer and entertainment technology company. The Company believes it creates extraordinary experiences at home and on the go for millions of consumers around the world, elevating content and how audiences connect with it in a way that is more intelligent, immersive and personal. Powering smart devices, connected cars, entertainment experiences and more, the Company has created a unified ecosystem that reaches highly engaged consumers, uncovering significant new business opportunities, now and in the future. The Company’s technologies are integrated into consumer devices and media platforms worldwide, driving increased value for partners, customers and consumers. The Company currently operates in one reportable business segment and groups its business into four categories based on the markets served: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Interim Financial Statements The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles (“GAAP”) in the United States (“U.S.”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. The amounts as of December 31, 2022 have been derived from the Company’s annual audited financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2022, filed on March 3, 2023 (the “Form 10-K”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with such rules and regulations. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary (consisting of normal recurring adjustments) to state fairly the financial position of the Company and its results of operations and cash flows as of and for the periods presented. These financial statements should be read in conjunction with the annual audited financial statements and notes thereto as of and for the year ended December 31, 2022, included in the Form 10-K. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2023 or any future period and the Company makes no representations related thereto. In the Condensed Consolidated Balance Sheet as of December 31, 2022 included in this Form 10-Q filing, the Company has revised the long-term deferred tax liabilities and other long-term liabilities line items to correct an immaterial error in the classification of unrecognized tax benefits. The adjustment results in a $ 7.7 million decrease of long-term deferred tax liabilities and an increase in other long-term liabilities. The revision has no impact on total long-term liabilities as of December 31, 2022. In relation to this adjustment, the Company will revise its Consolidated Statement of Cash Flows for the year ended December 31, 2022 to decrease deferred income tax and increase changes in operating assets and liabilities: accrued and other liabilities by $ 7.7 million with no changes to net cash from operating activities for 2022. The Company determined that the error was not material to any of its prior annual and interim period financial statements, and correcting it had no impact to the condensed consolidated financial statements for the three months ended March 31, 2023. Basis of Presentation During the three months ended September 30, 2022, all of the assets and liabilities of the Xperi Product business had been transferred to a legal entity (the “Transfer”) under the common control of Xperi. Subsequent to this transfer and through December 31, 2022, the Company's financial statements and accompanying notes are prepared on a consolidated basis and include Xperi and its subsidiaries in which Xperi has a controlling financial interest. All intercompany balances and transactions are eliminated in consolidation. Prior to the Transfer, the financial statements and accompanying notes of the Xperi Product business were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of the Former Parent as the Company was not historically held by a single legal entity. All intercompany balances and transactions within the combined businesses of the Company have been eliminated. The Condensed Consolidated Balance Sheets of Xperi and its subsidiaries for the pre-Transfer periods include Former Parent’s assets and liabilities that are specifically identifiable or otherwise attributable to the Company. In the fourth quarter of 2018, the Company funded a new subsidiary, Perceive Corporation (“Perceive”), which was created to focus on delivering edge inference solutions. As of March 31, 2023, the Company owned approximately 77.0 % of the outstanding equity interest of Perceive. The operating results of Perceive have been included in the Company’s condensed consolidated financial statements since the fourth quarter of 2018. Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements as the Former Parent used a centralized approach to cash management and financing its operations. Financial transactions relating to the Company were accounted for as equity contributions from the Former Parent on the Condensed Consolidated Balance Sheets. Accordingly, none of the Former Parent’s cash and cash equivalents were allocated to the Company for any of the periods presented, unless those balances were directly attributable to the Company. The Company reflects transfers of cash to and from the Former Parent’s cash management system within equity as a component of Net investment by Former Parent on a combined basis and as a component of net capital contribution from Former Parent on a consolidated basis. Other than the debt incurred in connection with the acquisition of Vewd Software Holdings Limited (“Vewd”) discussed in Note 9, the Former Parent’s long-term debt has not been attributed to the Company for any of the periods presented because the Former Parent’s borrowings are not the legal obligation of the Company. The cash and cash equivalents, including the Company’s capitalization from Former Parent on September 30, 2022, is expected to be sufficient to support its operations, capital expenditures and income tax payments, in addition to any investments and other capital allocation needs for at least the next 12 months from the issuance date of these condensed consolidated financial statements. Prior to the Separation, the Condensed Consolidated Statements of Operations and Comprehensive Loss of the Company reflect allocations of general corporate expenses from the Former Parent, including, but not limited to, executive management, sales and marketing, finance, legal, information technology, employee benefits administration, stock-based compensation, treasury, risk management, procurement and other shared services. These allocations were made on a direct usage basis when identifiable, with the remainder allocated on a pro rata basis of billing, revenue, headcount or other measures as deemed appropriate. Management of the Company and Former Parent consider these allocations to be a reasonable reflection of the utilization of services by, or the benefits provided to, the Company. The allocations may not, however, reflect the expenses the Company would have incurred as a standalone company for the periods presented. Actual costs that may have been incurred if the Company had been a standalone company would depend on a number of factors, such as the chosen organizational structure, whether functions were outsourced or performed by employees and decisions with respect to areas such as facilities, information technology and operating infrastructure. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES There have been no significant changes in the Company’s significant accounting policies during the three months ended March 31, 2023, as compared to the significant accounting policies described in the Form 10-K. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include the estimation of licensees’ quarterly royalties prior to receiving the royalty reports, the determination of stand-alone selling price and the transaction price in an arrangement with multiple performance obligations, the assessment of useful lives and recoverability of other intangible assets and long-lived assets, recognition and measurement of current and deferred income tax assets and liabilities, the assessment of unrecognized tax benefits, and purchase accounting resulting from business combinations. Actual results experienced by the Company may differ from management’s estimates. Concentration of Credit and Other Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with large financial institutions, and at times, the deposits may exceed the federally insured limits. As part of its risk management processes, the Company performs periodic evaluations of the relative credit standing of these financial institutions. The Company has not sustained material credit losses from instruments held at these financial institutions. In addition, the Company has cash and cash equivalents held in international bank accounts that are denominated in various foreign currencies, and has established risk management strategies designed to minimize the impact of certain currency exchange rate fluctuations. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by its evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary but generally requires no collateral. There were no individually significant customers with revenue exceeding 10% of total revenue for the three months ended March 31, 2023 and 2022, or that represented 10 % or more of the Company's aggregate trade receivables as of March 31, 2023 and December 31, 2022. Recent Accounting Pronouncements There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements. |
Revenue
Revenue | 3 Months Ended |
Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | NOTE 3 – REVENUE Revenue Recognition General Revenue is recognized when control of the promised goods or services is transferred to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services, which may include various combinations of goods and services which are generally capable of being distinct and accounted for as separate performance obligations. Some of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are separately accounted for if they are distinct. In an arrangement with multiple performance obligations, the transaction price is allocated among the separate performance obligations on a relative stand-alone selling price basis. The determination of stand-alone selling price considers market conditions, the size and scope of the contract, customer and geographic information, and other factors. When observable prices are not available, stand-alone selling price for separate performance obligations is based on the cost-plus-margin approach, considering overall pricing objectives. When variable consideration is in the form of a sales-based or usage-based royalty in exchange for a license of technology or when a license of technology is the predominant item to which the variable consideration relates, revenue is recognized at the later of when the subsequent sale or usage occurs or the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied or partially satisfied. Description of Revenue-Generating Activities The Company derives the majority of its revenue from licensing its technology and solutions to customers. These arrangements are summarized as Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology. The timing of when performance obligations are satisfied, as well as the fee arrangements underlying each agreement, determine when revenue is recognized. Technology License Arrangements The Company licenses its audio, digital radio and imaging technology to consumer electronics (“CE”) manufacturers, automotive manufacturers or their supply chain partners. The Company generally recognizes royalty revenue from licenses based on units shipped or manufactured. Revenue is recognized in the period in which the customer’s sales or production are estimated to have occurred. This may result in an adjustment to revenue when actual sales or production are subsequently reported by the customer, generally in the month or quarter following sales or production. Estimating customers’ quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis. Certain customers enter into fixed fee or minimum guarantee agreements, whereby customers pay a fixed fee for the right to incorporate the Company’s technology in the customer’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the technology and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer. Technology Solutions Arrangements Technology Solutions customers are primarily multi-channel video service providers, CE manufacturers, and end consumers. Technology Solutions revenue is primarily derived from licensing the Company’s Pay-TV solutions, Personalized Content Discovery, enriched Metadata, and viewership data; selling TiVo-enabled devices like the TiVo Stream 4K; and advertising. For Technology Solutions, the Company provides on-going media or data delivery, hosting and access to its platform, and software updates. For these solutions, the Company generally receives fees on a per-subscriber per-month basis or as a fixed fee, and revenue is recognized during the month in which the solutions are provided to the customer. For most of the Technology Solutions offerings, substantially all functionality is obtained through the Company’s continuous hosting and/or updating of the data and content. In these instances, the Company typically has a single performance obligation related to these ongoing activities in the underlying arrangement. For those arrangements that include multiple performance obligations, the Company allocates the consideration as described above and recognizes revenue for each distinct performance obligation when control of the promised goods or services is transferred to the customer. The Company also generates revenue from non-recurring engineering (“NRE”) services, advertising, and hardware products, each of which was less than 10% of tot al revenue for all periods presented. Revenue Details The following information depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors by disaggregating revenue by market and geographic location. Revenue disaggregated by market was as follows (in thousands): Three Months Ended March 31, 2023 2022 Pay-TV $ 60,294 $ 64,155 Consumer Electronics 36,735 28,091 Connected Car 20,548 19,719 Media Platform 9,262 6,923 Total revenue $ 126,839 $ 118,888 A significant portion of the Company’s revenue is derived from licensees headquartered outside of the U.S., principally in Asi a, Europe and the Middle East, and it is expected that this revenue will continue to account for a significant portion of total revenue in future periods. The following table presents the Company’s revenue disaggregated by geographic area (in thousands): Three Months Ended March 31, 2023 2022 U.S. $ 65,159 51 % $ 59,671 50 % Japan 17,495 14 15,550 13 China 11,510 9 10,292 9 Europe and Middle East 10,166 8 11,688 10 Other 22,509 18 21,687 18 $ 126,839 100 % $ 118,888 100 % Contract Balances Contracts Assets Contract assets primarily consist of unbilled contracts receivable that are expected to be received from customers in future periods, where the revenue recognized to date exceeds the amount billed. The amount of unbilled contracts receivable may not exceed their net realizable value and are classified as long-term assets if the payments are expected to be received more than one year from the reporting date. Contract assets also include the incremental costs of obtaining a contract with a customer consisting of principally sales commissions, and deferred engineering costs for non-recurring engineering and set-up services to the extent deemed recoverable. Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands): March 31, 2023 December 31, 2022 Unbilled contracts receivable, net $ 69,120 $ 65,251 Other current assets 758 848 Long-term unbilled contracts receivable 9,563 4,289 Other long-term assets 924 978 Total contract assets $ 80,365 $ 71,366 Contract Liabilities Contract liabilities are mainly comprised of deferred revenue related to technology solutions arrangements, multi-period licensing, and other offerings for which the Company is paid in advance while the promised good or service is transferred to the customer at a future date or over time. Deferred revenue also includes amounts received related to professional services to be performed in the future. Deferred revenue arises when cash payments are received, including amounts which are refundable, in advance of performance obligations being completed. Allowance for Credit Losses The allowance for credit losses, which includes the allowance for accounts receivable and unbilled contracts receivable, represents the Company’s best estimate of lifetime expected credit losses inherent in those financial assets. The Company’s lifetime expected credit losses are determined using relevant information about past events (including historical experience), current conditions, and reasonable and supportable forecasts that affect collectability. The Company monitors its credit exposure through ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary. In addition, the Company performs routine credit management activities such as timely account reconciliations, dispute resolution, and payment confirmations. The Company may employ collection agencies and legal counsel to pursue recovery of defaulted receivables. The Company’s long-term unbilled contracts receivable is derived from fixed-fee or minimum-guarantee arrangements, primarily with large well-capitalized companies. It is generally considered to be of high credit quality due to past collection history and the nature of the customers. The following table presents the activity in the allowance for credit losses for the three months ended March 31, 2023 and 2022 (in thousands): Three Months Ended March 31, 2023 2022 Accounts Receivable Unbilled Contracts Receivable Accounts Receivable Unbilled Contracts Receivable Beginning balance $ 1,950 $ 369 $ 2,255 $ 468 Provision for credit losses 136 ( 19 ) ( 180 ) ( 111 ) Recoveries/charge-off ( 19 ) — ( 114 ) 12 Balance at end of period $ 2,067 $ 350 $ 1,961 $ 369 Additional Disclosures The following table presents additional revenue and contract disclosures (in thousands): Three Months Ended March 31, 2023 2022 Revenue recognized in the period from: Amounts included in deferred revenue at the beginning of $ 6,719 $ 8,332 Performance obligations satisfied in previous periods (true (1) $ ( 1,881 ) $ 36 (1) True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation or disputes during the period for past royalties owed. Remaining revenue under contracts with performance obligations represents the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) under certain of the Company’s fixed fee arrangements and engineering services contracts. As of March 31, 2023, the Company’s remaining revenue under contracts with performance obligations was as follows (in thousands): Year Ending December 31: Revenue from contracts with performance obligations expected to be satisfied in: 2023 (remaining 9 months) $ 43,341 2024 29,679 2025 16,240 2026 5,485 2027 1,270 Thereafter 683 Total $ 96,698 |
Composition of Certain Financia
Composition of Certain Financial Statement Captions | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Composition of Certain Financial Statement Captions | NOTE 4 – COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS Other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Prepaid income tax $ 679 $ 1,777 Prepaid expenses 21,789 20,001 Finished goods inventory 6,539 6,662 Other 17,829 13,734 Total $ 46,836 $ 42,174 Property and equipment, net, consisted of the following (in thousands): March 31, 2023 December 31, 2022 Equipment, furniture and other $ 81,997 $ 78,976 Building and improvements 18,331 18,331 Land 5,300 5,300 Leasehold improvements 16,582 17,038 Total property and equipment 122,210 119,645 Less: accumulated depreciation and amortization ( 75,128 ) ( 71,818 ) Property and equipment, net $ 47,082 $ 47,827 Accrued liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Employee compensation and benefits $ 32,090 $ 53,546 Third-party royalties 8,145 7,620 Accrued expenses 23,023 22,928 Current portion of operating lease liabilities 16,298 17,195 Accrued income tax 2,131 4,926 Other 5,671 3,799 Total $ 87,358 $ 110,014 Accumulated other comprehensive income (loss) (“AOCI”) consisted of the following (in thousands): Unrealized Gains (Losses) on Cash Flow Hedges Foreign Currency Translation Adjustment Total Balance at December 31, 2022 $ ( 94 ) $ ( 4,025 ) $ ( 4,119 ) Other comprehensive income before reclassification 859 613 1,472 Amounts reclassified from accumulated other comprehensive loss into net loss 4 — 4 Net current period other comprehensive income 863 613 1,476 Balance at March 31, 2023 $ 769 $ ( 3,412 ) $ ( 2,643 ) Unrealized Gains (Losses) on Cash Flow Hedges Foreign Currency Translation Adjustment Total Balance at December 31, 2021 $ — $ ( 676 ) $ ( 676 ) Other comprehensive loss before reclassification — ( 1,046 ) ( 1,046 ) Net current period other comprehensive loss — ( 1,046 ) ( 1,046 ) Balance at March 31, 2022 $ — $ ( 1,722 ) $ ( 1,722 ) |
Financial Instruments
Financial Instruments | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Financial Instruments | NOTE 5 – FINANCIAL INSTRUMENTS Non-marketable Equity Securities As of March 31, 2023 and December 31, 2022, other long-term assets included equity securities accounted for under the equity method with a carrying amount o f $ 4.9 m illion and $ 4.4 million, respectively. No impairments to the carrying amount of the Company’s non-marketable equity securities were recognized in the three months ended March 31, 2023 and 2022, respectively. Derivatives Instruments In the fourth quarter of 2022, the Company began to use derivative financial instruments to manage foreign currency exchange rate risk. The Company’s derivative financial instruments consist of foreign currency forward contracts, which are used primarily to hedge portions of its anticipated foreign currency exposure. The maturities of these instruments are generally less than twelve months. Fair values for derivative financial instruments are based on prices computed using third-party valuation models and are classified as Level 2 in accordance with the three-level hierarchy of fair value measurements. All the significant inputs to the third-party valuation models are observable in active markets. Inputs include current market-based parameters such as forward rates, yield curves and credit default swap pricing. For additional information related to the three-level hierarchy of fair value measurements, see Note 6 – Fair Value . The notional and fair values of all derivative instruments were as follows (in thousands): March 31, 2023 December 31, 2022 Derivative instruments in cash flow hedges (foreign exchange contracts): Assets Other current assets $ 769 $ — Liabilities Accrued liabilities — 94 Total fair value $ 769 $ 94 Total notional value $ 58,817 $ 52,197 Undesignated derivative instruments (foreign exchange contracts): Assets Other current assets $ 277 $ — Liabilities Accrued liabilities — 41 Total fair value $ 277 $ 41 Total notional value $ 9,531 $ 7,402 All of the Company's derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparty to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's Condensed Consolidated Balance Sheets on a net basis. The gross amounts of the Company's foreign currency forward contracts and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets were as follows (in thousands): March 31, 2023 December 31, 2022 Gross amount of recognized assets $ 1,078 $ — Gross amount of recognized liabilities ( 32 ) ( 135 ) Net amount presented in the Condensed Consolidated Balance Sheets $ 1,046 $ ( 135 ) Cash Flow Hedges The Company designates certain foreign currency forward contracts as hedging instruments pursuant to ASC 815, Derivatives Composition of Certain Financial Statement Captions. The Company expects to reclassify to earnings all of the amounts recorded in AOCI associated with its cash flow hedges over the next twelve months. For the three months ended March 31, 2023, amounts reclassified to net loss were not significant. The Company did not enter into any derivative contracts prior to the fourth quarter of 2022. Undesignated Derivatives For derivatives that are not designated as hedge instruments, they are measured and reported at fair value. Changes in the fair h quarter of 2022. |
Fair Value
Fair Value | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value | NOTE 6 – FAIR VALUE The Company follows the authoritative guidance for fair value measurement and the fair value option for financial assets and financial liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets. Level 2 Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. When applying fair value principles in the valuation of assets, the Company is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The Company calculates the fair value of its Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments, where available, or based on other observable inputs. The Company’s derivative financial instruments, consisting of foreign currency forward contracts, are reported at fair value and classified as Level 2 (as described in Note 5 – Financial Instruments ). Financial Instruments Not Recorded at Fair Value The Company’s long-term debt is carried at historical cost and is measured at fair value on a quarterly basis for disclosure purposes. The carrying amounts and estimated fair values were as follows (in thousands): March 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Senior Unsecured Promissory Note $ 50,000 $ 49,062 $ 50,000 $ 48,478 If reported at fair value in the Condensed Consolidated Balance Sheets, the Company’s debt would be classified within Level 2 of the fair value hierarchy. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues. For more detail related to the senior unsecured promissory note, refer to Note 9 – Debt. Non-Recurring Fair Value Measurements For purchase accounting related fair value measurements, see Note 7 – Business Combination . |
Business Combination
Business Combination | 3 Months Ended |
Mar. 31, 2023 | |
Business Combinations [Abstract] | |
Business Combination | NOTE 7 – BUSINESS COMBINATION On July 1, 2022, the Company completed the acquisition of Vewd Software Holdings Limited (“Vewd,” and the “Vewd Acquisition”). Vewd is a leading global provider of OTT and hybrid TV solutions. The Vewd Acquisition establishes the Company as a leading independent streaming media platform through its TiVo brand and the largest independent provider of Smart TV middleware globally. The total consideration was approximately $ 102.9 million, consisting of approximately $ 52.9 million of cash and $ 50.0 million of deb t. Refer to Note 9 – Debt for additional information on this debt. Purchase Price Allocation The Vewd Acquisition has been accounted for as a business combination, using the acquisition method. The following table presents the allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on the fair values at the acquisition date with no measurement period adjustments identified (amounts in thousands, except estimated useful life): Estimated Useful Final Cash and cash equivalents $ 2,684 Accounts receivable 3,341 Unbilled contracts receivable 2,335 Other current assets 1,208 Property and equipment 443 Operating lease right-of-use assets 2,020 Identifiable intangible assets: Technology 7 $ 28,050 Customer relationships – large 7 4,900 Customer relationships – small 4 3,500 Non-compete agreements 2 870 Trade name 5 830 Total identifiable intangible assets 38,150 Goodwill 68,115 Other long-term assets 977 Accounts payable ( 869 ) Accrued liabilities ( 4,777 ) Deferred revenue ( 920 ) Long-term deferred tax liabilities ( 8,393 ) Noncurrent operating lease liabilities ( 1,094 ) Other long-term liabilities ( 307 ) Total purchase price $ 102,913 Vewd’s results of operations and cash flows have been included in the Company’s condensed consolidated financial statements for periods subsequent to July 1, 2022, and the related assets and liabilities were recorded at their estimated fair values in the Company’s Condensed Consolidated Balance Sheet as of July 1, 2022. Goodwill impairment During the three months ended September 30, 2022, indicators of potential impairment for the Former Parent’s Product reporting unit were identified such that management concluded it was more-likely-than-not that goodwill was impaired and a quantitative interim goodwill impairment assessment should be performed as of September 30, 2022. Indicators of potential impairment included a sustained decline in the Former Parent’s stock price during the second half of the third quarter of 2022 reflective of rising interest rates and continued decline in macroeconomic conditions. The Company proceeded to perform a fair value analysis of the Product reporting unit using the market capitalization approach. Under this approach, management estimated the fair value of the Product reporting unit as of September 30, 2022 using quoted market prices of Xperi’s common stock, over its first ten trading days following the Separation, and a control premium representing the synergies a market participant would achieve upon obtaining control of Xperi. As a result of the fair value analysis, the Company recognized a goodwill impairment charge of $ 354.0 million during the three months ended September 30, 2022. Leveraging the aforementioned fair value assessment, the Company also completed its annual goodwill impairment test as of October 1, 2022 using the financial information as of September 30, 2022. During the three months ended December 31, 2022, sufficient indicators of potential impairment were identified such that management concluded it was more-likely-than-not that goodwill was impaired and a quantitative interim goodwill impairment test should be performed as of December 31, 2022. Indicators of potential impairment included a significant, sustained decline in the trading price of Xperi’s common stock during the fourth quarter of 2022. The Company proceeded to perform a fair value analysis of the Product reporting unit, the Company's only reporting unit, using the market capitalization approach. Under this approach, management estimated the fair value as of December 31, 2022 using quoted market prices of Xperi’s common stock as of December 30, 2022, the last trading date of 2022, and a control premium representing the synergies a market participant would achieve upon obtaining control of Xperi. As a result of the fair value analysis, a goodwill impairment charge of $ 250.6 million was recognized during the three months ended December 31, 2022. As a result of this impairment charge, the Company's goodwill balance was reduced to $ 0 as of December 31, 2022. |
Intangible Assets, Net
Intangible Assets, Net | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets, Net | NOTE 8 – INTANGIBLE ASSETS, NET Identified intangible assets consisted of the following (in thousands): March 31, 2023 Average Life Gross Amount Accumulated Net Carrying Value Finite-lived intangible assets: Acquired patents 3 - 10 $ 22,189 $ ( 6,728 ) $ 15,461 Existing technology / content database 5 - 10 240,994 ( 193,863 ) 47,131 Customer contracts and related relationships 3 - 9 502,260 ( 345,740 ) 156,520 Trademarks/trade name 4 - 10 39,613 ( 30,988 ) 8,625 Non-competition agreements 1 - 2 3,101 ( 2,557 ) 544 Total finite-lived intangible assets 808,157 ( 579,876 ) 228,281 Indefinite-lived intangible assets: TiVo tradename/trademarks N/A 21,400 — 21,400 Total intangible assets $ 829,557 $ ( 579,876 ) $ 249,681 December 31, 2022 Average Life Gross Amount Accumulated Net Carrying Value Finite-lived intangible assets: Acquired patents 3 - 10 $ 22,189 $ ( 6,175 ) $ 16,014 Existing technology / content database 5 - 10 240,894 ( 190,671 ) 50,223 Customer contracts and related relationships 3 - 9 502,188 ( 335,981 ) 166,207 Trademarks/trade name 4 - 10 39,613 ( 29,733 ) 9,880 Non-competition agreements 1 - 2 3,101 ( 2,449 ) 652 Total finite-lived intangible assets 807,985 ( 565,009 ) 242,976 Indefinite-lived intangible assets: TiVo tradename/trademarks N/A 21,400 — 21,400 Total intangible assets $ 829,385 $ ( 565,009 ) $ 264,376 As of March 31, 2023, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands): Year Ending December 31: 2023 (remaining 9 months) $ 42,944 2024 43,384 2025 34,786 2026 31,490 2027 30,647 Thereafter 45,030 Total future amortization $ 228,281 |
Debt
Debt | 3 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | NOTE 9 – DEBT In connection with the Vewd Acquisition as disclosed in Note 7, on July 1, 2022, TiVo Product Holdco LLC, which was subsequently renamed Xperi Inc., issued a senior unsecured promissory note (the “Promissory Note”) to the sellers of Vewd in a principal amount of $ 50.0 million. Indebtedness outstanding under the Promissory Note bears an interest rate of 6.00 % per annum, payable in cash on a quarterly basis. If a certain qualified spin-off transaction occurs, the interest rate will be increased to the greater of (a) 6.00 % and (b) the sum of (i) the highest interest rate payable under any credit facility or bonds, debentures, notes or similar instruments where the issuer or any guarantor borrows money or guarantees obligations on a secured basis on or after the date of such spin-off transaction, plus (ii) 2.00 %. It was determined that the Spin-Off completed on October 1, 2022 did not trigger any change in the interest rate of the debt. The Promissory Note matures on July 1, 2025 . The Company may, at any time and on any one or more occasions, prepay all or any portion of the outstanding principal amount, plus accrued and unpaid interest, if any, under the Promissory Note without premium or penalty. In addition, the Promissory Note has mandatory prepayment provisions upon certain change of control or asset sale events. The Promissory Note includes certain covenants that restrict the Company and each guarantor’s ability to, among other things, incur certain indebtedness or engage in any material line of business substantially different from those lines of business conducted by such entities on the closing date of the acquisition. The Promissory Note does not contain any financial covenants. As of March 31, 2023, $ 50.0 million in principal balance was outstanding. Interest expense on the Promissory Note was $ 0.7 million for the three months ended March 31, 2023. The Company did not incur any new debt in the first quarter of 2022. |
Net Loss Per Share
Net Loss Per Share | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | NOTE 10 – NET LOSS PER SHARE On October 1, 2022, 42,023,632 shares of the Company’s common stock, par value $ 0.001 per share, were distributed to the Former Parent’s stockholders of record as of September 21, 2022 . This share amount is utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Separation and such shares are treated as issued and outstanding for purposes of calculating historical loss per share. For periods prior to the Separation, it is assumed that there are no dilutive equity instruments as there were no Xperi Inc. stock-based awards outstanding prior to the Separation. For periods subsequent to the Separation, actual outstanding shares are used to calculate both basic and diluted weighted- average number of common shares outstanding. Potentially dilutive common shares, such as common shares issuable upon exercise of stock options and vesting of restricted stock awards and units are typically reflected in the computation of diluted net income (loss) per share by application of the treasury stock method. Due to the net losses reported, these potentially dilutive securities were excluded from the computation of diluted net loss per share, since their effect would be anti-dilutive. The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amount): Three Months Ended March 31, 2023 2022 Numerator: Net loss attributable to the Company - basic and diluted $ ( 32,000 ) $ ( 29,523 ) Denominator: Weighted-average number of shares used to compute net loss per share attributable to the Company - basic and diluted 42,224 42,024 Net loss per share attributable to the Company - basic and diluted $ ( 0.76 ) $ ( 0.70 ) The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the period presented (in thousands): Three Months Ended March 31, 2023 Options 124 Restricted stock awards and units 7,219 ESPP 460 Total 7,803 |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stockholders' Equity | NOTE 11 – STOCKHOLDERS' EQUITY Equity Incentive Plans In connection with the Separation and on October 1, 2022, the Company adopted the Xperi Inc. 2022 Equity Incentive Plan (the “2022 EIP”). Under the 2022 EIP, the Company may grant equity-based awards to employees, non-employee directors, and consultants for services rendered to the Company (or any parent or subsidiary) in the form of stock options, stock awards, restricted stock awards, restricted stock units, stock appreciation rights, dividend equivalents and performance awards (or any combination thereof). A total of 10,100,000 shares were reserved for issuance under the 2022 EIP as of the Separation Date. The 2022 EIP provides for option grants designated as either incentive stock options or non-statutory options. Options have been granted with an exercise price not less than the value of the common stock on the grant date and generally have a term of ten years from the date of grant and vest over a four-year period. The vesting criteria for restricted stock awards and restricted stock units has historically been the passage of time or meeting certain performance-based objectives, and continued service through the vesting period over three or four years for time-based awards or three years for performance-based awards. As of March 31, 2023, there were approximately 4.4 million shares reserved for future grant under the 2022 EIP. Stock Options A summary of the stock option activity is presented below (in thousands, except per share amounts): Options Outstanding Number of Weighted Balance at December 31, 2022 146 $ 25.48 Options canceled / forfeited / expired ( 22 ) $ 21.13 Balance at March 31, 2023 124 $ 26.27 Restricted Stock Awards and Units Information with respect to outstanding restricted stock awards and units (including both time-based vesting and performance-based vesting) as of March 31, 2023 is as follows (in thousands, except per share amounts): Restricted Stock and Restricted Stock Units Number of Number of Total Weighted Balance at December 31, 2022 3,713 891 4,604 $ 20.35 Awards and units granted 2,682 718 3,400 $ 11.56 Awards and units vested / earned ( 697 ) — ( 697 ) $ 20.59 Awards and units canceled / forfeited ( 88 ) — ( 88 ) $ 17.53 Balance at March 31, 2023 5,610 1,609 7,219 $ 16.23 Performance-Based Stock Awards and Units Performance-based stock awards and units (“PSUs”) may be granted to employees or consultants based upon, among other things, the contributions, responsibilities and other compensation of the particular employee or consultant. The value and the vesting of such PSUs are generally linked to one or more performance goals or certain market conditions determined by the Company, in each case on a specified date or dates or over any period or periods determined by the Company, and may range from zero to 200 percent of the grant. For PSUs subject to a market vesting condition, the fair value per award is fixed at the grant date and the amount of compensation expense is not adjusted during the performance period regardless of changes in the level of achievement of the market condition. Employee Stock Purchase Plans In connection with the Separation and on October 1, 2022, the Company adopted the Xperi Inc. 2022 Employee Stock Purchase Plan (the “2022 ESPP”). The 2022 ESPP is implemented through consecutive overlapping 24 -month offering periods, each of which is comprised of four six-month purchase periods. The first offering period commenced on December 1, 2022 and will end on November 30, 2024. Each subsequent offering period under the 2022 ESPP will be twenty-four (24) months long and will commence on each December 1 and June 1 during the term of the plan. Participants may contribute up to 100 % of their base earnings and commissions through payroll deductions, and the accumulated deductions will be applied to the purchase of shares on each semi-annual purchase date. The purchase price per share will equal 85 % of the fair market value per share on the start date of the offering period or, if lower, 85 % of the fair market value per share on the semi-annual purchase date. An eligible employee’s right to buy the Company’s common stock under the 2022 ESPP may not accrue at a rate in excess of $ 25,000 of the fair market value of such shares per calendar year for each calendar year of an offering period. If the fair market value per share of the Company’s common stock on any purchase date during an offering period is less than the fair market value per share on the start date of the 24 -month offering period, then that offering period will automatically terminate and a new 24 -month offering period will begin on the next business day. All participants in the terminated offering will be transferred to the new offering period. As of March 31, 2023, there w ere 5.0 millio n shares reserved for grant under the 2022 ESPP. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | NOTE 12 – STOCK-BASED COMPENSATION Prior to the Separation, the stock-based compensation expense was based on the expense for employees specifically identifiable to Xperi. Consequently, the amounts presented are not necessarily indicative of future awards and do not necessarily reflect the costs that the Company would have incurred as an independent company. The effect of recording stock-based compensation expense for the three months ended March 31, 2023 and 2022 is as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue, excluding depreciation and amortization of intangible assets $ 792 $ 625 Research and development 5,551 5,099 Selling, general and administrative 9,625 2,913 Total stock-based compensation expense $ 15,968 $ 8,637 In connection with the conversion of the Former Parent’s PSUs into PSUs with respect to Xperi common stock and Adeia common stock, the Company continued recognizing an incremental compensation expense of $ 1.4 million during the three months ended March 31, 2023. Stock-based compensation expense categorized by various equity components for the three months ended March 31, 2023 and 2022 is summarized in the table below (in thousands): Three Months Ended March 31, 2023 2022 Restricted stock awards and units $ 14,980 $ 7,823 Employee stock purchase plan 988 814 Total stock-based compensation expense $ 15,968 $ 8,637 In addition, for the three months ended March 31, 2022, $ 2.5 million of stock-based compensation expense was recognized in operating results as part of the corporate and shared functional employees expenses allocation. The following assumptions were used to value the PSUs subject to market conditions granted during the period: March 2023 Expected life (years) 2.8 Risk-free interest rate 4.5 % Dividend yield 0.0 % Expected volatility 49.0 % The Company uses the Black-Scholes option pricing model to determine the estimated fair value of options and ESPP shares. There were no stock options granted during the three months ended March 31, 2023 and 2022. The following assumptions were used to value the Company’s ESPP shares offered in December 2022: December 2022 Expected life (years) 2.0 Risk-free interest rate 4.3 % Dividend yield 0.0 % Expected volatility 42.9 % Prior to the Separation, the valuation assumptions were determined by the Former Parent. The following assumptions were used to value the Former Parent’s ESPP shares granted to employees specifically identifiable March 2022 Expected life (years) 2.0 Risk-free interest rate 1.3 % Dividend yield 1.1 % Expected volatility 48.5 % |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | NOTE 13 – INC OME TAXES For the three months ended March 31, 2023, the Company recorded an income tax benefit of $ 0.3 million on pretax loss of $ 33.2 million, which resulted in an effective tax rate of 0.9 %. The income tax benefit for the three months ended March 31, 2023 was primarily related to foreign withholding taxes, partially offset by U.S. federal income taxes and state income taxes. For the three months ended March 31, 2022, the Company recorded an income tax expense of $ 2.1 million on pretax loss of $ 28.4 million, which resulted in an effective tax rate of ( 7.3 )%. The income tax expense for the three months ended March 31, 2022 was primarily related to foreign withholding taxes, U.S. federal income taxes, and state income taxes. As of March 31, 2023, gross unrecognized tax benefits of $ 19.4 million increased by an insignificant amount compared to December 31, 2022. Unrecognized tax benefits were included in long-term deferred tax and other long-term li abilities on the Condensed Consolidated Balance Sheets. Of the $ 19.4 million, $ 8.8 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of the long-term payments or the amount by which the liability will increase or decrease. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company recognized an immaterial amount of interest and penalties related to unrecognized tax benefits for the three months ended March 31, 2023 and 2022, respectively. Accrued interest and penalties were $ 0.1 million and $ 0.1 million as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023, the Company’s 2018 through 2023 tax years are generally open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examinatio n. |
Leases
Leases | 3 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
Leases | NOTE 14 – LE ASES The Company leases office and research facilities, data centers and office equipment under operating leases which expire through 2029. The Company’s leases have remaining lease terms of one to six yea rs , with some of the leases offering the option to renew for up to five years and to terminate the lease before the expiration date. Leases with an initial term of 12 months or less are not recorded on the balance sheets ; expense for these leases is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the lease liability and right-of-use assets calculation. The Company subleases certain real estate to third parties. The sublease portfolio consists of operating leases for previously exited office space. Certain subleases include variable payments for operating costs. The subleases are generally co-terminus with the head lease, or shorter. Subleases do not include any residual value guarantees or restrictions or covenants imposed by the leases. Income from subleases is recognized as a reduction to selling, general and administrative expenses. As a result of consolidating our global real estate footprint and decisions to vacate and sublease certain offices following the Spin-off, the Company recorded impairment charges of $ 1.1 million to r educe the carrying amount of certain operating lease right-of-use (“ROU”) assets and property and equipment, including leasehold improvements, during the three months ended March 31, 2023. The Company determined that it may not be able to fully recover the carrying amount of the leased offices due to a change in the manner in which the offices are being used, a significant decrease in the expected market price of the leased asset, and expected delays in subleasing the space based on the current real estate leasing market. The Company estimated the fair value using a discounted cash flows approach with assumptions such as expectations of cash flows from projected sublease income, occupancy estimates and its outlook for the local real estate market. The components of operating lease costs were as follows (in thousands): Three Months Ended March 31, 2023 2022 Fixed lease cost (1) $ 5,158 $ 5,023 Variable lease cost 1,487 1,056 Less: sublease income ( 2,680 ) ( 2,106 ) Total operating lease cost $ 3,965 $ 3,973 (1) Includes short-term leases expensed on a straight-line basis. The following table presents supplemental cash flow information arising from lease transactions (in thousands): Three Months Ended March 31, 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 5,208 $ 5,035 Operating ROU assets obtained in exchange for lease obligations $ — $ 584 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: March 31, December 31, 2022 Weighted-average remaining lease term (in years) 3.47 3.69 Weighted-average discount rate 5.1 % 5.1 % Future minimum lease payments and related lease liabilities as of March 31, 2023 were as follows (in thousands): Operating Lease Payments (1) Sublease Income Net Operating Lease Payments 2023 (remaining 9 months) $ 13,744 $ ( 5,612 ) $ 8,132 2024 17,907 ( 7,572 ) 10,335 2025 15,397 ( 7,386 ) 8,011 2026 7,523 ( 935 ) 6,588 2027 2,711 — 2,711 Thereafter 1,773 — 1,773 Total lease payments 59,055 $ ( 21,505 ) $ 37,550 Less: imputed interest ( 5,307 ) Present value of lease liabilities: $ 53,748 Less: current obligations under leases (accrued liabilities) ( 16,298 ) Noncurrent operating lease liabilities $ 37,450 (1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOT E 15 – COMMITMENTS AND CONTINGENCIES Purchase and Other Contractual Obligations In the ordinary course of business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements primarily include unconditional purchase obligations to service providers. As of March 31, 2023, the Company’s total future unconditional purchase obligations were approximately $ 93.5 million. Additionally, under certain other contractual arrangements, the Company may be obligated to pay up to $ 1.3 million, a majority of which is expected to be paid within the next year , if certain milestones are achieved. Inventory Purchase Commitment The Company uses contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and help ensure adequate supply, the Company enters into agreements with its contract manufacturers that either allow them to procure inventory based on criteria as defined by the Company or that establish the parameters defining the Company’s requirements. A significant portion of the Company’s purchase commitments arising from these agreements consist of firm, non-cancelable and unconditional purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule or adjust the Company’s requirements based on its business needs prior to firm orders being placed. As of March 31, 2023, the Company had total purchase commitments for inventory of $ 2.8 million. Indemnifications In the normal course of business, the Company provides indemnifications of varying scopes and amounts to certain of its licensees, customers, and business partners against claims made by third parties arising from the use of the Company's products, intellectual property, services or technologies. The Company cannot reasonably estimate the possible range of losses that may be incurred pursuant to its indemnification obligations, if any. Variables affecting any such assessment include, but are not limited to: the scope of the contractual indemnification obligation; the nature of the third party claim asserted; the relative merits of the third party claim; the financial ability of the third party claimant to engage in protracted litigation; the number of parties seeking indemnification; the nature and amount of damages claimed by the party suing the indemnified party; and the willingness of such party to engage in settlement negotiations. The Company has received requests for indemnification, but to date none has been material and no liability has been recorded in the Company’s financial statements. As permitted under Delaware law, the Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company believes, given the absence of any such payments in the Company’s history, and the estimated low probability of such payments in the future, that the estimated fair value of these indemnification agreements is immaterial. In addition, the Company has directors’ and officers’ liability insurance coverage that is intended to reduce its financial exposure and may enable the Company to recover any payments under the indemnification agreements, should they occur. Contingencies The Company and its subsidiaries have been involved in litigation matters and claims in the normal course of business. In the past, the Company or its subsidiaries have litigated to enforce their respective patents and other intellectual property rights, to enforce the terms of license agreements, to determine infringement or validity of intellectual property rights, and to defend themselves or their customers against claims of infringement or breach of contract. The Company expects it or its subsidiaries will be involved in similar legal proceedings in the future, including proceedings to ensure proper and full payment of royalties by licensees under the terms of their license agreements. An adverse decision in any legal actions could result in a loss of the Company’s proprietary rights, subject the Company to significant liabilities, require the Company to seek licenses from others, limit the value of the Company’s licensed technology or otherwise negatively impact the Company’s stock price or its business and consolidated financial results. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NO TE 16 – RELATED PARTY TRANSACTIONS For periods prior to the Separation, the Condensed Consolidated Financial Statements have been prepared on a standalone basis and were derived from the condensed consolidated financial statements and accounting records of the Former Parent. The following disclosure summarizes activity prior to the Separation between the Company and the Former Parent, including affiliates of the Former Parent that were not part of the Separation. Allocation of Corporate Expenses Prior to Separation, the Condensed Consolidated Financial Statements included expenses for certain management and support functions which were provided on a centralized basis within the Former Parent, as described in “Note 1 – The Company and Basis of Presentation.” These management and support functions include, but are not limited to, executive management, sales and marketing, finance, legal, information technology, employee benefits administration, stock-based compensation, treasury, risk management, procurement and other shared services. These allocations were made on a direct usage basis when identifiable, with the remainder allocated on a pro rata basis of billing, revenue, headcount or other measures of the Company and the Former Parent. The amount of these allocations from the Former Parent was $ 15.0 million, which included $ 1.2 million for depreciation expenses and $ 13.8 million for selling, general and administrative for the three months ended March 31, 2022. Management believes these cost allocations are a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Company during the periods presented. The allocations may not, however, be indicative of the actual expenses that would have been incurred had the Company operated as a standalone public company. Actual costs that may have been incurred if the Company had been a standalone public company would depend on a number of factors, such as the chosen organizational structure, whether functions were outsourced or performed by Company’s employees, and strategic decisions made in areas such as selling, information technology and infrastructure. Net Investment by Former Parent As a result of the Company consolidating its financial results, as described in Note 1, net investment by Former Parent in the Condensed Consolidated Balance Sheets and Statement of Equity was fully settled. As such, there was no balance in net Investment by Former Parent at December 31, 2022, and there was no activity within the account during the three months ended March 31, 2023. Prior to the Company consolidating its financial results, net investment by Former Parent in the historical Balance Sheets and Statement of Equity represented the Former Parent's historical investment in the Company, the net effect of transactions with and allocations from the Former Parent, and the Company’s accumulated deficit. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation During the three months ended September 30, 2022, all of the assets and liabilities of the Xperi Product business had been transferred to a legal entity (the “Transfer”) under the common control of Xperi. Subsequent to this transfer and through December 31, 2022, the Company's financial statements and accompanying notes are prepared on a consolidated basis and include Xperi and its subsidiaries in which Xperi has a controlling financial interest. All intercompany balances and transactions are eliminated in consolidation. Prior to the Transfer, the financial statements and accompanying notes of the Xperi Product business were prepared on a combined basis and were derived from the consolidated financial statements and accounting records of the Former Parent as the Company was not historically held by a single legal entity. All intercompany balances and transactions within the combined businesses of the Company have been eliminated. The Condensed Consolidated Balance Sheets of Xperi and its subsidiaries for the pre-Transfer periods include Former Parent’s assets and liabilities that are specifically identifiable or otherwise attributable to the Company. In the fourth quarter of 2018, the Company funded a new subsidiary, Perceive Corporation (“Perceive”), which was created to focus on delivering edge inference solutions. As of March 31, 2023, the Company owned approximately 77.0 % of the outstanding equity interest of Perceive. The operating results of Perceive have been included in the Company’s condensed consolidated financial statements since the fourth quarter of 2018. Prior to the Separation, the Company was dependent on the Former Parent for all of its working capital and financing requirements as the Former Parent used a centralized approach to cash management and financing its operations. Financial transactions relating to the Company were accounted for as equity contributions from the Former Parent on the Condensed Consolidated Balance Sheets. Accordingly, none of the Former Parent’s cash and cash equivalents were allocated to the Company for any of the periods presented, unless those balances were directly attributable to the Company. The Company reflects transfers of cash to and from the Former Parent’s cash management system within equity as a component of Net investment by Former Parent on a combined basis and as a component of net capital contribution from Former Parent on a consolidated basis. Other than the debt incurred in connection with the acquisition of Vewd Software Holdings Limited (“Vewd”) discussed in Note 9, the Former Parent’s long-term debt has not been attributed to the Company for any of the periods presented because the Former Parent’s borrowings are not the legal obligation of the Company. The cash and cash equivalents, including the Company’s capitalization from Former Parent on September 30, 2022, is expected to be sufficient to support its operations, capital expenditures and income tax payments, in addition to any investments and other capital allocation needs for at least the next 12 months from the issuance date of these condensed consolidated financial statements. Prior to the Separation, the Condensed Consolidated Statements of Operations and Comprehensive Loss of the Company reflect allocations of general corporate expenses from the Former Parent, including, but not limited to, executive management, sales and marketing, finance, legal, information technology, employee benefits administration, stock-based compensation, treasury, risk management, procurement and other shared services. These allocations were made on a direct usage basis when identifiable, with the remainder allocated on a pro rata basis of billing, revenue, headcount or other measures as deemed appropriate. Management of the Company and Former Parent consider these allocations to be a reasonable reflection of the utilization of services by, or the benefits provided to, the Company. The allocations may not, however, reflect the expenses the Company would have incurred as a standalone company for the periods presented. Actual costs that may have been incurred if the Company had been a standalone company would depend on a number of factors, such as the chosen organizational structure, whether functions were outsourced or performed by employees and decisions with respect to areas such as facilities, information technology and operating infrastructure. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include the estimation of licensees’ quarterly royalties prior to receiving the royalty reports, the determination of stand-alone selling price and the transaction price in an arrangement with multiple performance obligations, the assessment of useful lives and recoverability of other intangible assets and long-lived assets, recognition and measurement of current and deferred income tax assets and liabilities, the assessment of unrecognized tax benefits, and purchase accounting resulting from business combinations. Actual results experienced by the Company may differ from management’s estimates. |
Concentration of Credit and Other Risks | Concentration of Credit and Other Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with large financial institutions, and at times, the deposits may exceed the federally insured limits. As part of its risk management processes, the Company performs periodic evaluations of the relative credit standing of these financial institutions. The Company has not sustained material credit losses from instruments held at these financial institutions. In addition, the Company has cash and cash equivalents held in international bank accounts that are denominated in various foreign currencies, and has established risk management strategies designed to minimize the impact of certain currency exchange rate fluctuations. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by its evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary but generally requires no collateral. There were no individually significant customers with revenue exceeding 10% of total revenue for the three months ended March 31, 2023 and 2022, or that represented 10 % or more of the Company's aggregate trade receivables as of March 31, 2023 and December 31, 2022. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements There have been no recently issued accounting pronouncements that are expected to have a material impact on the Company's condensed consolidated financial statements. |
Revenue Recognition | Revenue Recognition General Revenue is recognized when control of the promised goods or services is transferred to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services, which may include various combinations of goods and services which are generally capable of being distinct and accounted for as separate performance obligations. Some of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are separately accounted for if they are distinct. In an arrangement with multiple performance obligations, the transaction price is allocated among the separate performance obligations on a relative stand-alone selling price basis. The determination of stand-alone selling price considers market conditions, the size and scope of the contract, customer and geographic information, and other factors. When observable prices are not available, stand-alone selling price for separate performance obligations is based on the cost-plus-margin approach, considering overall pricing objectives. When variable consideration is in the form of a sales-based or usage-based royalty in exchange for a license of technology or when a license of technology is the predominant item to which the variable consideration relates, revenue is recognized at the later of when the subsequent sale or usage occurs or the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied or partially satisfied. Description of Revenue-Generating Activities The Company derives the majority of its revenue from licensing its technology and solutions to customers. These arrangements are summarized as Technology License arrangements and Technology Solutions arrangements. For Technology License arrangements, the customer obtains rights to the technology delivered at the commencement of the agreement. For Technology Solutions arrangements, the customer receives access to a platform, media or data that includes frequent updates, where access to such updates is critical to the functionality of the technology. The timing of when performance obligations are satisfied, as well as the fee arrangements underlying each agreement, determine when revenue is recognized. Technology License Arrangements The Company licenses its audio, digital radio and imaging technology to consumer electronics (“CE”) manufacturers, automotive manufacturers or their supply chain partners. The Company generally recognizes royalty revenue from licenses based on units shipped or manufactured. Revenue is recognized in the period in which the customer’s sales or production are estimated to have occurred. This may result in an adjustment to revenue when actual sales or production are subsequently reported by the customer, generally in the month or quarter following sales or production. Estimating customers’ quarterly royalties prior to receiving the royalty reports requires the Company to make significant assumptions and judgments related to forecasted trends and growth rates used to estimate quantities shipped or manufactured by customers, which could have a material impact on the amount of revenue it reports on a quarterly basis. Certain customers enter into fixed fee or minimum guarantee agreements, whereby customers pay a fixed fee for the right to incorporate the Company’s technology in the customer’s products over the license term. In arrangements with a minimum guarantee, the fixed fee component corresponds to a minimum number of units or dollars that the customer must produce or pay, with additional per-unit fees for any units or dollars exceeding the minimum. The Company generally recognizes the full fixed fee as revenue at the beginning of the license term when the customer has the right to use the technology and begins to benefit from the license, net of the effect of any significant financing components calculated using customer-specific, risk-adjusted lending rates, with the related interest income being recognized over time on an effective rate basis. For minimum guarantee agreements where the customer exceeds the minimum, the Company recognizes revenue relating to any additional per-unit fees in the periods it believes the customer will exceed the minimum and adjusts the revenue based on actual usage once that is reported by the customer. Technology Solutions Arrangements Technology Solutions customers are primarily multi-channel video service providers, CE manufacturers, and end consumers. Technology Solutions revenue is primarily derived from licensing the Company’s Pay-TV solutions, Personalized Content Discovery, enriched Metadata, and viewership data; selling TiVo-enabled devices like the TiVo Stream 4K; and advertising. For Technology Solutions, the Company provides on-going media or data delivery, hosting and access to its platform, and software updates. For these solutions, the Company generally receives fees on a per-subscriber per-month basis or as a fixed fee, and revenue is recognized during the month in which the solutions are provided to the customer. For most of the Technology Solutions offerings, substantially all functionality is obtained through the Company’s continuous hosting and/or updating of the data and content. In these instances, the Company typically has a single performance obligation related to these ongoing activities in the underlying arrangement. For those arrangements that include multiple performance obligations, the Company allocates the consideration as described above and recognizes revenue for each distinct performance obligation when control of the promised goods or services is transferred to the customer. The Company also generates revenue from non-recurring engineering (“NRE”) services, advertising, and hardware products, each of which was less than 10% of tot al revenue for all periods presented. |
Revenue (Tables)
Revenue (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenue Disaggregated by Product Category and Market | The following information depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors by disaggregating revenue by market and geographic location. Revenue disaggregated by market was as follows (in thousands): Three Months Ended March 31, 2023 2022 Pay-TV $ 60,294 $ 64,155 Consumer Electronics 36,735 28,091 Connected Car 20,548 19,719 Media Platform 9,262 6,923 Total revenue $ 126,839 $ 118,888 |
Schedule of Geographic Revenue Information | The following table presents the Company’s revenue disaggregated by geographic area (in thousands): Three Months Ended March 31, 2023 2022 U.S. $ 65,159 51 % $ 59,671 50 % Japan 17,495 14 15,550 13 China 11,510 9 10,292 9 Europe and Middle East 10,166 8 11,688 10 Other 22,509 18 21,687 18 $ 126,839 100 % $ 118,888 100 % |
Schedule of Contract Assets | Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands): March 31, 2023 December 31, 2022 Unbilled contracts receivable, net $ 69,120 $ 65,251 Other current assets 758 848 Long-term unbilled contracts receivable 9,563 4,289 Other long-term assets 924 978 Total contract assets $ 80,365 $ 71,366 |
Schedule of Allowance for Credit Losses | The following table presents the activity in the allowance for credit losses for the three months ended March 31, 2023 and 2022 (in thousands): Three Months Ended March 31, 2023 2022 Accounts Receivable Unbilled Contracts Receivable Accounts Receivable Unbilled Contracts Receivable Beginning balance $ 1,950 $ 369 $ 2,255 $ 468 Provision for credit losses 136 ( 19 ) ( 180 ) ( 111 ) Recoveries/charge-off ( 19 ) — ( 114 ) 12 Balance at end of period $ 2,067 $ 350 $ 1,961 $ 369 |
Schedule of Revenue Recognized in Period | The following table presents additional revenue and contract disclosures (in thousands): Three Months Ended March 31, 2023 2022 Revenue recognized in the period from: Amounts included in deferred revenue at the beginning of $ 6,719 $ 8,332 Performance obligations satisfied in previous periods (true (1) $ ( 1,881 ) $ 36 (1) True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation or disputes during the period for past royalties owed. |
Schedule of Remaining Performance Obligations | Company’s remaining revenue under contracts with performance obligations was as follows (in thousands): Year Ending December 31: Revenue from contracts with performance obligations expected to be satisfied in: 2023 (remaining 9 months) $ 43,341 2024 29,679 2025 16,240 2026 5,485 2027 1,270 Thereafter 683 Total $ 96,698 |
Composition of Certain Financ_2
Composition of Certain Financial Statement Captions (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Other Current Assets | Other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Prepaid income tax $ 679 $ 1,777 Prepaid expenses 21,789 20,001 Finished goods inventory 6,539 6,662 Other 17,829 13,734 Total $ 46,836 $ 42,174 |
Schedule of Property and Equipment, Net | Property and equipment, net, consisted of the following (in thousands): March 31, 2023 December 31, 2022 Equipment, furniture and other $ 81,997 $ 78,976 Building and improvements 18,331 18,331 Land 5,300 5,300 Leasehold improvements 16,582 17,038 Total property and equipment 122,210 119,645 Less: accumulated depreciation and amortization ( 75,128 ) ( 71,818 ) Property and equipment, net $ 47,082 $ 47,827 |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands): March 31, 2023 December 31, 2022 Employee compensation and benefits $ 32,090 $ 53,546 Third-party royalties 8,145 7,620 Accrued expenses 23,023 22,928 Current portion of operating lease liabilities 16,298 17,195 Accrued income tax 2,131 4,926 Other 5,671 3,799 Total $ 87,358 $ 110,014 |
Schedule of Accumulated Other Comprehensive Income (Loss) (AOCI) | Accumulated other comprehensive income (loss) (“AOCI”) consisted of the following (in thousands): Unrealized Gains (Losses) on Cash Flow Hedges Foreign Currency Translation Adjustment Total Balance at December 31, 2022 $ ( 94 ) $ ( 4,025 ) $ ( 4,119 ) Other comprehensive income before reclassification 859 613 1,472 Amounts reclassified from accumulated other comprehensive loss into net loss 4 — 4 Net current period other comprehensive income 863 613 1,476 Balance at March 31, 2023 $ 769 $ ( 3,412 ) $ ( 2,643 ) Unrealized Gains (Losses) on Cash Flow Hedges Foreign Currency Translation Adjustment Total Balance at December 31, 2021 $ — $ ( 676 ) $ ( 676 ) Other comprehensive loss before reclassification — ( 1,046 ) ( 1,046 ) Net current period other comprehensive loss — ( 1,046 ) ( 1,046 ) Balance at March 31, 2022 $ — $ ( 1,722 ) $ ( 1,722 ) |
Financial Instruments (Tables)
Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Notional and Fair Values of All Derivative Instruments | The notional and fair values of all derivative instruments were as follows (in thousands): March 31, 2023 December 31, 2022 Derivative instruments in cash flow hedges (foreign exchange contracts): Assets Other current assets $ 769 $ — Liabilities Accrued liabilities — 94 Total fair value $ 769 $ 94 Total notional value $ 58,817 $ 52,197 Undesignated derivative instruments (foreign exchange contracts): Assets Other current assets $ 277 $ — Liabilities Accrued liabilities — 41 Total fair value $ 277 $ 41 Total notional value $ 9,531 $ 7,402 |
Schedule of Gross Amounts of Foreign Currency Forward Contracts | The gross amounts of the Company's foreign currency forward contracts and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets were as follows (in thousands): March 31, 2023 December 31, 2022 Gross amount of recognized assets $ 1,078 $ — Gross amount of recognized liabilities ( 32 ) ( 135 ) Net amount presented in the Condensed Consolidated Balance Sheets $ 1,046 $ ( 135 ) |
Fair Value (Tables)
Fair Value (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Carrying Amounts and Estimated Fair Values | The carrying amounts and estimated fair values were as follows (in thousands): March 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Senior Unsecured Promissory Note $ 50,000 $ 49,062 $ 50,000 $ 48,478 If reported at fair value in the Condensed Consolidated Balance Sheets, the Company’s debt would be classified within Level 2 of the fair value hierarchy. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues. For more detail related to the senior unsecured promissory note, refer to Note 9 – Debt. |
Business Combination (Tables)
Business Combination (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Vewd | |
Business Acquisition [Line Items] | |
Schedule of Estimated Fair Value that Allocated to Assets and Liabilities | The following table presents the allocation of the purchase price to the identifiable assets acquired and liabilities assumed based on the fair values at the acquisition date with no measurement period adjustments identified (amounts in thousands, except estimated useful life): Estimated Useful Final Cash and cash equivalents $ 2,684 Accounts receivable 3,341 Unbilled contracts receivable 2,335 Other current assets 1,208 Property and equipment 443 Operating lease right-of-use assets 2,020 Identifiable intangible assets: Technology 7 $ 28,050 Customer relationships – large 7 4,900 Customer relationships – small 4 3,500 Non-compete agreements 2 870 Trade name 5 830 Total identifiable intangible assets 38,150 Goodwill 68,115 Other long-term assets 977 Accounts payable ( 869 ) Accrued liabilities ( 4,777 ) Deferred revenue ( 920 ) Long-term deferred tax liabilities ( 8,393 ) Noncurrent operating lease liabilities ( 1,094 ) Other long-term liabilities ( 307 ) Total purchase price $ 102,913 |
Intangible Assets, Net (Tables)
Intangible Assets, Net (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Identified Intangible Assets | Identified intangible assets consisted of the following (in thousands): March 31, 2023 Average Life Gross Amount Accumulated Net Carrying Value Finite-lived intangible assets: Acquired patents 3 - 10 $ 22,189 $ ( 6,728 ) $ 15,461 Existing technology / content database 5 - 10 240,994 ( 193,863 ) 47,131 Customer contracts and related relationships 3 - 9 502,260 ( 345,740 ) 156,520 Trademarks/trade name 4 - 10 39,613 ( 30,988 ) 8,625 Non-competition agreements 1 - 2 3,101 ( 2,557 ) 544 Total finite-lived intangible assets 808,157 ( 579,876 ) 228,281 Indefinite-lived intangible assets: TiVo tradename/trademarks N/A 21,400 — 21,400 Total intangible assets $ 829,557 $ ( 579,876 ) $ 249,681 December 31, 2022 Average Life Gross Amount Accumulated Net Carrying Value Finite-lived intangible assets: Acquired patents 3 - 10 $ 22,189 $ ( 6,175 ) $ 16,014 Existing technology / content database 5 - 10 240,894 ( 190,671 ) 50,223 Customer contracts and related relationships 3 - 9 502,188 ( 335,981 ) 166,207 Trademarks/trade name 4 - 10 39,613 ( 29,733 ) 9,880 Non-competition agreements 1 - 2 3,101 ( 2,449 ) 652 Total finite-lived intangible assets 807,985 ( 565,009 ) 242,976 Indefinite-lived intangible assets: TiVo tradename/trademarks N/A 21,400 — 21,400 Total intangible assets $ 829,385 $ ( 565,009 ) $ 264,376 |
Estimated Future Amortization Expense | As of March 31, 2023, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands): Year Ending December 31: 2023 (remaining 9 months) $ 42,944 2024 43,384 2025 34,786 2026 31,490 2027 30,647 Thereafter 45,030 Total future amortization $ 228,281 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Computation of Basic and Diluted Net Loss Per Share | The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amount): Three Months Ended March 31, 2023 2022 Numerator: Net loss attributable to the Company - basic and diluted $ ( 32,000 ) $ ( 29,523 ) Denominator: Weighted-average number of shares used to compute net loss per share attributable to the Company - basic and diluted 42,224 42,024 Net loss per share attributable to the Company - basic and diluted $ ( 0.76 ) $ ( 0.70 ) |
Schedule of Potentially Dilutive Shares Were Excluded From Calculation of Diluted Net Loss Per Share | The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the period presented (in thousands): Three Months Ended March 31, 2023 Options 124 Restricted stock awards and units 7,219 ESPP 460 Total 7,803 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Stock Option Activity | A summary of the stock option activity is presented below (in thousands, except per share amounts): Options Outstanding Number of Weighted Balance at December 31, 2022 146 $ 25.48 Options canceled / forfeited / expired ( 22 ) $ 21.13 Balance at March 31, 2023 124 $ 26.27 |
Summary of Restricted Stock Awards and Units | Information with respect to outstanding restricted stock awards and units (including both time-based vesting and performance-based vesting) as of March 31, 2023 is as follows (in thousands, except per share amounts): Restricted Stock and Restricted Stock Units Number of Number of Total Weighted Balance at December 31, 2022 3,713 891 4,604 $ 20.35 Awards and units granted 2,682 718 3,400 $ 11.56 Awards and units vested / earned ( 697 ) — ( 697 ) $ 20.59 Awards and units canceled / forfeited ( 88 ) — ( 88 ) $ 17.53 Balance at March 31, 2023 5,610 1,609 7,219 $ 16.23 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Summary of Stock-Based Compensation Expense | The effect of recording stock-based compensation expense for the three months ended March 31, 2023 and 2022 is as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue, excluding depreciation and amortization of intangible assets $ 792 $ 625 Research and development 5,551 5,099 Selling, general and administrative 9,625 2,913 Total stock-based compensation expense $ 15,968 $ 8,637 |
Stock-Based Compensation Expense Categorized by Equity Components | Stock-based compensation expense categorized by various equity components for the three months ended March 31, 2023 and 2022 is summarized in the table below (in thousands): Three Months Ended March 31, 2023 2022 Restricted stock awards and units $ 14,980 $ 7,823 Employee stock purchase plan 988 814 Total stock-based compensation expense $ 15,968 $ 8,637 |
Employee Stock Purchase Plan | |
Schedule of Assumptions Used to Value Awards Granted | The following assumptions were used to value the Company’s ESPP shares offered in December 2022: December 2022 Expected life (years) 2.0 Risk-free interest rate 4.3 % Dividend yield 0.0 % Expected volatility 42.9 % Prior to the Separation, the valuation assumptions were determined by the Former Parent. The following assumptions were used to value the Former Parent’s ESPP shares granted to employees specifically identifiable March 2022 Expected life (years) 2.0 Risk-free interest rate 1.3 % Dividend yield 1.1 % Expected volatility 48.5 % |
Performance Stock Units | |
Schedule of Assumptions Used to Value Awards Granted | The following assumptions were used to value the PSUs subject to market conditions granted during the period: March 2023 Expected life (years) 2.8 Risk-free interest rate 4.5 % Dividend yield 0.0 % Expected volatility 49.0 % |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Leases [Abstract] | |
Schedule of Operating Lease Costs | The components of operating lease costs were as follows (in thousands): Three Months Ended March 31, 2023 2022 Fixed lease cost (1) $ 5,158 $ 5,023 Variable lease cost 1,487 1,056 Less: sublease income ( 2,680 ) ( 2,106 ) Total operating lease cost $ 3,965 $ 3,973 (1) Includes short-term leases expensed on a straight-line basis. |
Schedule of Supplemental Cash Flow Information arising from Lease Transactions | The following table presents supplemental cash flow information arising from lease transactions (in thousands): Three Months Ended March 31, 2023 2022 Cash payments included in the measurement of operating lease liabilities $ 5,208 $ 5,035 Operating ROU assets obtained in exchange for lease obligations $ — $ 584 |
Schedule of Weighted-average Remaining Term of Operating Leases and Weighted-average of Discount Rate of Present Value of Operating Lease Liabilities | The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: March 31, December 31, 2022 Weighted-average remaining lease term (in years) 3.47 3.69 Weighted-average discount rate 5.1 % 5.1 % |
Schedule of Future Minimum Lease Payments and Related Lease Liabilities | Future minimum lease payments and related lease liabilities as of March 31, 2023 were as follows (in thousands): Operating Lease Payments (1) Sublease Income Net Operating Lease Payments 2023 (remaining 9 months) $ 13,744 $ ( 5,612 ) $ 8,132 2024 17,907 ( 7,572 ) 10,335 2025 15,397 ( 7,386 ) 8,011 2026 7,523 ( 935 ) 6,588 2027 2,711 — 2,711 Thereafter 1,773 — 1,773 Total lease payments 59,055 $ ( 21,505 ) $ 37,550 Less: imputed interest ( 5,307 ) Present value of lease liabilities: $ 53,748 Less: current obligations under leases (accrued liabilities) ( 16,298 ) Noncurrent operating lease liabilities $ 37,450 (1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes. |
The Company and Basis of Pres_2
The Company and Basis of Presentation - Additional Information (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Oct. 01, 2022 $ / shares shares | Mar. 31, 2023 USD ($) Business Segment $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Sep. 21, 2022 $ / shares | |
Organization Consolidation And Presentation [Line Items] | ||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | ||
Common stock shares distributed | shares | 42,497,000 | 42,066,000 | ||
Number of reportable business segments | Segment | 1 | |||
Number of business category | Business | 4 | |||
Potentially dilutive common stock equivalents | shares | 7,803,000 | |||
Long-term deferred tax liabilities | $ 12,886 | $ 12,899 | ||
Other long-term liabilities | $ 11,828 | 12,990 | ||
Decrease deferred income tax | (7,700) | |||
Increase accrued and other liabilities | 7,700 | |||
Unrecognized Tax Benefits | ||||
Organization Consolidation And Presentation [Line Items] | ||||
Long-term deferred tax liabilities | (7,700) | |||
Other long-term liabilities | $ 7,700 | |||
Xperi Holding | ||||
Organization Consolidation And Presentation [Line Items] | ||||
Number of independent publicly traded companies | Business | 2 | |||
Number of intellectual property licensing business | Business | 1 | |||
Number of product business | Business | 1 | |||
Perceive Corporation | ||||
Organization Consolidation And Presentation [Line Items] | ||||
Ownership interest, percentage | 77% | |||
Spin-Off | Xperi Holding | ||||
Organization Consolidation And Presentation [Line Items] | ||||
Record date of outstanding common stock distribution for spinoff | Sep. 21, 2022 | |||
Number of shares received for every ten common stock shares held on record date | shares | 4 | |||
Number of common stock shares considered as one unit for issue of shares in spinoff | shares | 10 | |||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Additional Information (Details) - Credit Concentration Risk - Customer | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 | |
Aggregate trade receivables | Customer One | |||
Summary of Significant Accounting Policies [Line Items] | |||
Concentration risk, percentage (or more) | 10% | 10% | |
Revenue | |||
Summary of Significant Accounting Policies [Line Items] | |||
Number of customers, concentration of risk disclosure | 0 | 0 |
Revenue - Schedule of Revenue D
Revenue - Schedule of Revenue Disaggregated by Market (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 126,839 | $ 118,888 |
Pay TV | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 60,294 | 64,155 |
Consumer Electronics | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 36,735 | 28,091 |
Connected Car | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 20,548 | 19,719 |
Media Platform | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 9,262 | $ 6,923 |
Revenue - Schedule of Geographi
Revenue - Schedule of Geographic Revenue Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 126,839 | $ 118,888 |
Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 100% | 100% |
U.S | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 65,159 | $ 59,671 |
U.S | Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 51% | 50% |
Japan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 17,495 | $ 15,550 |
Japan | Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 14% | 13% |
China | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 11,510 | $ 10,292 |
China | Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 9% | 9% |
Europe and Middle East | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 10,166 | $ 11,688 |
Europe and Middle East | Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 8% | 10% |
Asia and other | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total revenue | $ 22,509 | $ 21,687 |
Asia and other | Total Revenue | Geographic Concentration Risk | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Concentration risk, percentage (or more) | 18% | 18% |
Revenue - Schedule of Contract
Revenue - Schedule of Contract Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Revenue from Contract with Customer [Abstract] | ||
Unbilled contracts receivable, net | $ 69,120 | $ 65,251 |
Other current assets | 758 | 848 |
Long-term unbilled contracts receivable | 9,563 | 4,289 |
Other long-term assets | 924 | 978 |
Total contract assets | $ 80,365 | $ 71,366 |
Revenue - Schedule of Allowance
Revenue - Schedule of Allowance for Credit Losses (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Accounts Receivable | ||
Accounts Notes And Loans Receivable [Line Items] | ||
Beginning balance | $ 1,950 | $ 2,255 |
Provision for credit losses | 136 | (180) |
Recoveries/charge-off | (19) | (114) |
Balance at end of period | 2,067 | 1,961 |
Unbilled Contracts Receivable | ||
Accounts Notes And Loans Receivable [Line Items] | ||
Beginning balance | 369 | 468 |
Provision for credit losses | (19) | (111) |
Recoveries/charge-off | 12 | |
Balance at end of period | $ 350 | $ 369 |
Revenue - Schedule of Revenue R
Revenue - Schedule of Revenue Recognized in Period (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | ||
Revenue from Contract with Customer [Abstract] | |||
Amounts included in deferred revenue at the beginning of the period | $ 6,719 | $ 8,332 | |
Performance obligations satisfied in previous periods (true ups, licensee reporting adjustments and settlements) | [1] | $ (1,881) | $ 36 |
[1] True ups represent the differences between the Company’s quarterly estimates of per-unit royalty revenue and actual production/sales-based royalties reported by licensees in the following period. Licensee reporting adjustments represent corrections or revisions to previously reported per-unit royalties by licensees, generally resulting from the Company’s inquiries or compliance audits. Settlements represent resolutions of litigation or disputes during the period for past royalties owed. |
Revenue - Schedule of Remaining
Revenue - Schedule of Remaining Performance Obligations (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 96,698 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-04-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 43,341 |
Performance obligations expected to be satisfied, expected timing | 9 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 29,679 |
Performance obligations expected to be satisfied, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 16,240 |
Performance obligations expected to be satisfied, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 5,485 |
Performance obligations expected to be satisfied, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 1,270 |
Performance obligations expected to be satisfied, expected timing | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Remaining performance obligations | $ 683 |
Performance obligations expected to be satisfied, expected timing | 1 year |
Revenue - Schedule of Remaini_2
Revenue - Schedule of Remaining Performance Obligations (Details 1) $ in Thousands | Mar. 31, 2023 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligations | $ 96,698 |
Composition of Certain Financ_3
Composition of Certain Financial Statement Captions - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Prepaid Income Tax | $ 679 | $ 1,777 |
Prepaid expenses | 21,789 | 20,001 |
Finished goods inventory | 6,539 | 6,662 |
Other | 17,829 | 13,734 |
Total | $ 46,836 | $ 42,174 |
Composition of Certain Financ_4
Composition of Certain Financial Statement Captions - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 122,210 | $ 119,645 |
Less: accumulated depreciation and amortization | (75,128) | (71,818) |
Property and equipment, net | 47,082 | 47,827 |
Equipment, furniture and other | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 81,997 | 78,976 |
Building and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 18,331 | 18,331 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 5,300 | 5,300 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 16,582 | $ 17,038 |
Composition of Certain Financ_5
Composition of Certain Financial Statement Captions - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Employee compensation and benefits | $ 32,090 | $ 53,546 | |
Third-party royalties | 8,145 | 7,620 | |
Accrued expenses | 23,023 | 22,928 | |
Current portion of operating lease liabilities | $ 16,298 | [1] | $ 17,195 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Total | Total | |
Accrued income tax | $ 2,131 | $ 4,926 | |
Other | 5,671 | 3,799 | |
Total | $ 87,358 | $ 110,014 | |
[1] Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes. |
Composition of Certain Financ_6
Composition of Certain Financial Statement Captions - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | $ 448,986 | $ 1,015,957 |
Other comprehensive income before reclassification | 1,472 | (1,046) |
Amounts reclassified from accumulated other comprehensive loss into net loss | 4 | |
Other comprehensive loss, net of tax | 1,476 | (1,046) |
Ending balance | 430,574 | 1,018,813 |
Unrealized Gains (Losses) on Cash Flow Hedges | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | (94) | |
Other comprehensive income before reclassification | 859 | |
Amounts reclassified from accumulated other comprehensive loss into net loss | 4 | |
Other comprehensive loss, net of tax | 863 | |
Ending balance | 769 | |
Foreign Currency Translation Adjustment | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | (4,025) | (676) |
Other comprehensive income before reclassification | 613 | (1,046) |
Other comprehensive loss, net of tax | 613 | (1,046) |
Ending balance | (3,412) | (1,722) |
Accumulated Other Comprehensive Loss | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | (4,119) | (676) |
Other comprehensive loss, net of tax | 1,476 | (1,046) |
Ending balance | $ (2,643) | $ (1,722) |
Financial Instruments - Additio
Financial Instruments - Additional Information (Details) - TiVo Merger - Non-marketable Equity Securities - USD ($) | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Schedule Of Investments [Line Items] | |||
Equity securities accounted for under equity method | $ 4,900,000 | $ 4,400,000 | |
Impairment charges related to non-marketable equity securities | $ 0 | $ 0 |
Financial Instruments - Schedul
Financial Instruments - Schedule of Notional and Fair Values of All Derivative Instruments (Details) - Foreign Exchange Contracts - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Designated Derivative Instruments | Cash Flow Hedging [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Other current assets | $ 769 | |
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current |
Accrued liabilities | $ 94 | |
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued Liabilities, Current | Accrued Liabilities, Current |
Total fair value | $ 769 | $ 94 |
Total notional value | 58,817 | $ 52,197 |
Undesignated Derivative Instruments | ||
Derivatives, Fair Value [Line Items] | ||
Other current assets | $ 277 | |
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current | Other Assets, Current |
Accrued liabilities | $ 41 | |
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued Liabilities, Current | Accrued Liabilities, Current |
Total fair value | $ 277 | $ 41 |
Total notional value | $ 9,531 | $ 7,402 |
Financial Instruments - Sched_2
Financial Instruments - Schedule of Gross Amounts of Foreign Currency Forward Contracts (Details) - Foreign Exchange Contracts - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Derivatives, Fair Value [Line Items] | ||
Gross amount of recognized assets | $ 1,078 | |
Gross amount of recognized liabilities | (32) | $ (135) |
Net liability presented in the Consolidated Balance Sheets | $ 1,046 | $ (135) |
Fair Value - Schedule of Carryi
Fair Value - Schedule of Carrying Amounts and Estimated Fair Values (Details) - Recurring - Senior Unsecured Promissory Note - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Total long-term debt, net - Carrying Amount | $ 50,000 | $ 50,000 |
Total long-term debt, net - Estimated Fair Value | $ 49,062 | $ 48,478 |
Business Combination - Addition
Business Combination - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||||
Jul. 01, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Mar. 31, 2022 | |
Business Acquisition [Line Items] | |||||
Goodwill impairment charge | $ 250,600 | $ 354,000 | |||
Goodwill | $ 0 | ||||
Revenue: | $ 126,839 | $ 118,888 | |||
Operating loss | $ (33,601) | $ (28,926) | |||
Vewd | |||||
Business Acquisition [Line Items] | |||||
Purchase price | $ 102,913 | ||||
Cash included in the total consideration | 52,900 | ||||
Debt included in the total consideration | 50,000 | ||||
Goodwill | $ 68,115 |
Business Combination - Schedule
Business Combination - Schedule of Purchase Price Allocation (Details) - USD ($) $ in Thousands | Jul. 01, 2022 | Dec. 31, 2022 |
Identifiable intangible assets: | ||
Goodwill | $ 0 | |
Vewd | ||
Business Acquisition [Line Items] | ||
Cash and cash equivalents | $ 2,684 | |
Accounts receivable | 3,341 | |
Unbilled contracts receivable | 2,335 | |
Other current assets | 1,208 | |
Property and equipment | 443 | |
Operating lease right-of-use assets | 2,020 | |
Identifiable intangible assets: | ||
Identifiable intangible assets | 38,150 | |
Goodwill | 68,115 | |
Other long-term assets | 977 | |
Accounts payable | (869) | |
Accrued liabilities | (4,777) | |
Deferred revenue | (920) | |
Long-term deferred tax liabilities | (8,393) | |
Noncurrent operating lease liabilities | (1,094) | |
Other long-term liabilities | (307) | |
Total purchase price | $ 102,913 | |
Vewd | Technology | ||
Business Acquisition [Line Items] | ||
Estimated Useful Life (years) | 7 years | |
Identifiable intangible assets: | ||
Identifiable intangible assets | $ 28,050 | |
Vewd | Customer Relationships - Large | ||
Business Acquisition [Line Items] | ||
Estimated Useful Life (years) | 7 years | |
Identifiable intangible assets: | ||
Identifiable intangible assets | $ 4,900 | |
Vewd | Customer Relationships - Small | ||
Business Acquisition [Line Items] | ||
Estimated Useful Life (years) | 4 years | |
Identifiable intangible assets: | ||
Identifiable intangible assets | $ 3,500 | |
Vewd | Non-competition agreements | ||
Business Acquisition [Line Items] | ||
Estimated Useful Life (years) | 2 years | |
Identifiable intangible assets: | ||
Identifiable intangible assets | $ 870 | |
Vewd | Trade name | ||
Business Acquisition [Line Items] | ||
Estimated Useful Life (years) | 5 years | |
Identifiable intangible assets: | ||
Identifiable intangible assets | $ 830 |
Intangible Assets, Net - Identi
Intangible Assets, Net - Identified Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 829,557 | $ 829,385 |
Finite-lived intangible assets, Gross Assets | 808,157 | 807,985 |
Finite-lived intangible assets, Accumulated Amortization | (579,876) | (565,009) |
Intangible assets, net | 249,681 | 264,376 |
Finite-lived intangible assets, Net | 228,281 | 242,976 |
TiVo tradename/trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Indefinite-lived intangible assets, Gross Assets | 21,400 | 21,400 |
Indefinite-lived intangible assets, Net | 21,400 | 21,400 |
Acquired patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, Gross Assets | 22,189 | 22,189 |
Finite-lived intangible assets, Accumulated Amortization | (6,728) | (6,175) |
Finite-lived intangible assets, Net | $ 15,461 | $ 16,014 |
Acquired patents | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 3 years | 3 years |
Acquired patents | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 10 years | 10 years |
Existing technology / content database | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, Gross Assets | $ 240,994 | $ 240,894 |
Finite-lived intangible assets, Accumulated Amortization | (193,863) | (190,671) |
Finite-lived intangible assets, Net | $ 47,131 | $ 50,223 |
Existing technology / content database | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 5 years | 5 years |
Existing technology / content database | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 10 years | 10 years |
Customer contracts and related relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, Gross Assets | $ 502,260 | $ 502,188 |
Finite-lived intangible assets, Accumulated Amortization | (345,740) | (335,981) |
Finite-lived intangible assets, Net | $ 156,520 | $ 166,207 |
Customer contracts and related relationships | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 3 years | 3 years |
Customer contracts and related relationships | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 9 years | 9 years |
Trademarks/trade name | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, Gross Assets | $ 39,613 | $ 39,613 |
Finite-lived intangible assets, Accumulated Amortization | (30,988) | (29,733) |
Finite-lived intangible assets, Net | $ 8,625 | $ 9,880 |
Trademarks/trade name | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 4 years | 4 years |
Trademarks/trade name | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 10 years | 10 years |
Non-competition agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, Gross Assets | $ 3,101 | $ 3,101 |
Finite-lived intangible assets, Accumulated Amortization | (2,557) | (2,449) |
Finite-lived intangible assets, Net | $ 544 | $ 652 |
Non-competition agreements | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 1 year | 1 year |
Non-competition agreements | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Estimated Useful Life (years) | 2 years | 2 years |
Intangible Assets, Net - Estima
Intangible Assets, Net - Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2023 (remaining 9 months) | $ 42,944 | |
2024 | 43,384 | |
2025 | 34,786 | |
2026 | 31,490 | |
2027 | 30,647 | |
Thereafter | 45,030 | |
Finite-lived intangible assets, Net | $ 228,281 | $ 242,976 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Jul. 01, 2022 | Mar. 31, 2023 | |
Promissory Note | ||
Line Of Credit Facility [Line Items] | ||
Interest expense | $ 0.7 | |
Vewd | Promissory Note | ||
Line Of Credit Facility [Line Items] | ||
Debt instrument, principal amount | $ 50 | |
Interest rate | 6% | |
Debt instrument, basis spread on variable rate | 2% | |
Debt instrument, maturity date | Jul. 01, 2025 | |
2021 Convertible Notes | ||
Line Of Credit Facility [Line Items] | ||
Borrowings | $ 50 |
Net Loss Per Share - Additional
Net Loss Per Share - Additional Information (Details) - $ / shares | Oct. 01, 2022 | Mar. 31, 2023 | Dec. 31, 2022 |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Common stock, shares issued (in shares) | 42,497,000 | 42,066,000 | |
Common stock, par value | $ 0.001 | $ 0.001 | |
Spin-Off | Xperi Inc. | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Common stock, shares issued (in shares) | 42,023,632 | ||
Common stock, par value | $ 0.001 | ||
Record date of outstanding common stock distribution for spinoff | Sep. 21, 2022 |
Net Loss Per Share - Computatio
Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Numerator: | ||
Net loss attributable to the Company - basic | $ (32,000) | $ (29,523) |
Net loss attributable to the Company - diluted | $ (32,000) | $ (29,523) |
Denominator: | ||
Weighted-average number of shares used to compute net loss per share attributable to the Company - basic | 42,224 | 42,024 |
Weighted-average number of shares used to compute net loss per share attributable to the Company - diluted | 42,224 | 42,024 |
Net loss per share attributable to the Company - basic | $ (0.76) | $ (0.70) |
Net loss per share attributable to the Company - diluted | $ (0.76) | $ (0.70) |
Net Loss Per Share - Schedule o
Net Loss Per Share - Schedule of Potentially Dilutive Shares Were Excluded From Calculation of Diluted Net Loss Per Share (Details) shares in Thousands | 3 Months Ended |
Mar. 31, 2023 shares | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |
Potentially dilutive common stock equivalents | 7,803 |
Options | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |
Potentially dilutive common stock equivalents | 124 |
Restricted Stock Awards and Units | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |
Potentially dilutive common stock equivalents | 7,219 |
ESPP | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |
Potentially dilutive common stock equivalents | 460 |
Stockholders' Equity (Additiona
Stockholders' Equity (Additional Information) (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) shares | |
Employee Stock Purchase Plan | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Expiration period | 24 months |
Number of shares reserved for issuance | 5,000,000 |
Maximum employee subscription rate | 100% |
Purchase price of common stock, percent | 85% |
Maximum employee subscription amount | $ | $ 25,000,000 |
Rolling expiration period | 24 months |
Performance Shares | Minimum [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Grant Available To Vest | 0% |
Performance Shares | Maximum [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Grant Available To Vest | 200% |
2022 EIP | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Number of shares reserved for issuance | 10,100,000 |
Shares reserved for grant (in shares) | 4,400,000 |
Stockholder's Equity - Summary
Stockholder's Equity - Summary of Stock Option Activity (Details) shares in Thousands | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Number of Shares Subject to Options | |
Number of Shares, Beginning balance (shares) | shares | 146 |
Number of Shares, Options canceled / forfeited / expired (shares) | shares | (22) |
Number of Shares, Ending balance (shares) | shares | 124 |
Weighted Average Exercise Price Per Share | |
Weighted Average Exercise Price Per Share, Beginning balance (USD per share) | $ / shares | $ 25.48 |
Weighted Average Exercise Price Per Share, Options canceled / forfeited / expired (USD per share) | $ / shares | 21.13 |
Weighted Average Exercise Price Per Share, Ending balance (USD per share) | $ / shares | $ 26.27 |
Stockholder's Equity - Summar_2
Stockholder's Equity - Summary of Restricted Stock Awards and Units (Details) shares in Thousands | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Time-Based Restricted Stock Award and Restricted Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Restricted stock awards and units, beginning balance (shares) | 3,713 |
Restricted stock awards and units, granted (shares) | 2,682 |
Restricted stock awards and units, vested / earned (shares) | (697) |
Restricted stock awards and units, canceled / forfeited (shares) | (88) |
Restricted stock awards and units, ending balance (shares) | 5,610 |
Performance-Based Restricted Stock Award and Restricted Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Restricted stock awards and units, beginning balance (shares) | 891 |
Restricted stock awards and units, granted (shares) | 718 |
Restricted stock awards and units, ending balance (shares) | 1,609 |
Restricted Stock and Restricted Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Restricted stock awards and units, beginning balance (shares) | 4,604 |
Restricted stock awards and units, granted (shares) | 3,400 |
Restricted stock awards and units, vested / earned (shares) | (697) |
Restricted stock awards and units, canceled / forfeited (shares) | (88) |
Restricted stock awards and units, ending balance (shares) | 7,219 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | |
Weighted average grant date fair value per share of restricted stock and units, beginning balance (USD per share) | $ / shares | $ 20.35 |
Weighted average grant date fair value per share of restricted stock and units, granted (USD per share) | $ / shares | 11.56 |
Weighted average grant date fair value per share of restricted stock and units, vested / earned (USD per share) | $ / shares | 20.59 |
Weighted average grant date fair value of restricted stock and units, canceled / forfeited (USD per share) | $ / shares | 17.53 |
Weighted average grant date fair value per share of restricted stock and units, ending balance (USD per share) | $ / shares | $ 16.23 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | $ 15,968 | $ 8,637 |
Cost of revenue, excluding depreciation and amortization of intangible assets | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | 792 | 625 |
Research and development | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | 5,551 | 5,099 |
Selling, general and administrative | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | $ 9,625 | $ 2,913 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Stock-based compensation expense recognized | $ 15,968 | $ 8,637 |
Incremental stock based compensation expense | $ 1,400 | |
Number of shares, options granted | 0 | 0 |
Corporate and Shared Functional Employees | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Stock-based compensation expense recognized | $ 2,500 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock-Based Compensation Expense Categorized by Equity Components (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 15,968 | $ 8,637 |
Employee Stock Purchase Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 988 | 814 |
Restricted Stock and Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 14,980 | $ 7,823 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Assumptions Used to Value Awards Granted (Details) | 1 Months Ended | ||
Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 | |
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | |||
Expected life (in years) | 2 years | 2 years | |
Risk-free interest rate | 4.30% | 1.30% | |
Dividend yield | 0% | 1.10% | |
Expected volatility | 42.90% | 48.50% | |
Performance Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | |||
Expected life (in years) | 2 years 9 months 18 days | ||
Risk-free interest rate | 4.50% | ||
Dividend yield | 0% | ||
Expected volatility | 49% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |||
Provision for (benefit from) income taxes | $ (294) | $ 2,080 | |
Effective tax rate (percent) | 0.90% | 7.30% | |
Income (loss) before taxes | $ (33,233) | $ (28,411) | |
Increase in gross unrecognized tax benefits | 19,400 | ||
Unrecognized tax benefits that would impact the effective income tax rate | 8,800 | ||
Accrued interest and tax penalties related to unrecognized tax benefits | $ 100 | $ 100 | |
Income tax examination description | As of March 31, 2023, the Company’s 2018 through 2023 tax years are generally open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examinatio |
Leases - Additional Information
Leases - Additional Information (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Lessee Lease Description [Line Items] | |
Operating lease existence of option to renew | true |
Operating lease description | The Company’s leases have remaining lease terms of one to six years, with some of the leases offering the option to renew for up to five years and to terminate the lease before the expiration date. Leases with an initial term of 12 months or less are not recorded on the balance sheets |
Impairment charges on operating lease ROU assets and property and equipment including leasehold impariments | $ 1.1 |
Minimum | |
Lessee Lease Description [Line Items] | |
Remaining lease term | 1 year |
Maximum | |
Lessee Lease Description [Line Items] | |
Remaining lease term | 6 years |
Lessee term of period to renew | 5 years |
Leases - Schedule of Operating
Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | ||
Leases [Abstract] | |||
Fixed lease cost | [1] | $ 5,158 | $ 5,023 |
Variable lease cost | 1,487 | 1,056 | |
Less: sublease income | (2,680) | (2,106) | |
Total operating lease cost | $ 3,965 | $ 3,973 | |
[1] Includes short-term leases expensed on a straight-line basis. |
Leases - Schedule Of Cash Flow
Leases - Schedule Of Cash Flow Supplemental Disclosures (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Leases [Abstract] | ||
Cash payments included in the measurement of operating lease liabilities | $ 5,208 | $ 5,035 |
Operating ROU assets obtained in exchange for lease obligations | $ 584 |
Leases - Schedule of Weighted-a
Leases - Schedule of Weighted-average Remaining Term of Operating Leases and Weighted-average of Discount Rate of Present Value of Operating Lease Liabilities (Details) | Mar. 31, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Weighted-average remaining lease term ( in years) | 3 years 5 months 19 days | 3 years 8 months 8 days |
Weighted-average discount rate | 5.10% | 5.10% |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments and Related Lease Liabilities (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | ||
Operating Lease Payments | ||||
2023 (remaining 9 months) | [1] | $ 13,744 | ||
2024 | [1] | 17,907 | ||
2025 | [1] | 15,397 | ||
2026 | [1] | 7,523 | ||
2027 | [1] | 2,711 | ||
Thereafter | [1] | 1,773 | ||
Total lease payments | [1] | 59,055 | ||
Less: imputed interest | [1] | (5,307) | ||
Present value of lease liabilities: | [1] | 53,748 | ||
Less: current obligations under leases (accrued liabilities) | (16,298) | [1] | $ (17,195) | |
Operating lease liabilities, noncurrent | 37,450 | [1] | $ 42,666 | |
Sublease Income | ||||
2023 (remaining 9 months) | (5,612) | |||
2024 | (7,572) | |||
2025 | (7,386) | |||
2026 | 935 | |||
Total lease payments | 21,505 | |||
Net Operating Lease Payments | ||||
2023 (remaining 9 months) | 8,132 | |||
2024 | 10,335 | |||
2025 | 8,011 | |||
2026 | 6,588 | |||
2027 | 2,711 | |||
Thereafter | 1,773 | |||
Total lease payments | $ 37,550 | |||
[1] Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes. |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Commitments And Contingencies Disclosure [Line Items] | |
Purchase commitments | $ 93.5 |
Other Contractual Arrangements | |
Commitments And Contingencies Disclosure [Line Items] | |
Contractual obligation expected payment period | 1 year |
Other Contractual Arrangements | Maximum | |
Commitments And Contingencies Disclosure [Line Items] | |
Contractual obligation | $ 1.3 |
Inventory | |
Commitments And Contingencies Disclosure [Line Items] | |
Purchase commitments | $ 2.8 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Related Party Transaction [Line Items] | ||
Depreciation expense | $ 4,093 | $ 5,563 |
Selling, general and administrative | $ 57,776 | 49,852 |
Parent | ||
Related Party Transaction [Line Items] | ||
Amount of allocations from parent | 15,000 | |
Depreciation expense | 1,200 | |
Selling, general and administrative | $ 13,800 |